PPD-SNBL in Japan

How We Help Expertise Asia Pacific PPD-SNBL in Japan

Local management and global-scale capabilities

PPD’s partnership with Shin Nippon Biomedical Laboratories Ltd. (SNBL), a proven Japanese Clinical Research Organization (CRO), provides local, on-the-ground management. This joint venture brings deep knowledge of Japanese culture and regulations, in addition to the confidence that comes from accessing the breadth and quality of services and tools you would expect from a leading global CRO. PPD-SNBL’s unique model demonstrates our understanding of the need for local and cultural alignment.

0

years of local experience

patients icon
0 +

patients

0 +

running global studies

0 +

sites

0 +

clinical trials in five years

Teamwork icon
0 +

PPD-SNBL team members in 3 cities

Why PPD-SNBL in Japan?

PPD-SNBL has a long history of excellence in Japan, having partnered with more than 20 international pharmaceutical companies on over 150 studies in Japan. Our partners have recognized and provided positive evaluations related to our performance and delivery. We offer full-service capabilities and apply our strong, growing team to ensure excellence in clinical trial delivery.

HIGH QUALITY

PPD-SNBL has an excellent track record of providing high quality services. We operate according to ICH-GCP standards and have had no critical findings from audit agencies following multiple inspections.

SINGLE ACCOUNTABILITY MODEL

Accountability and decision-making stays in Japan. A single CRA manages the entire study from start up to study closure with all functional leaders in Japan reporting directly to the PPD-SNBL general manager.

LOW TURNOVER RATES

Named the fifth-fastest-growing business in Japan by Randstad, PPD-SNBL has been recognized for staff retention success in a highly competitive recruiting market.

PPD-SNBL provides a full range of Clinical Development expertise in Phase I-IV clinical capabilities to support global or local trials, including:

Consulting expertise:

  • NDA strategy
  • KOL development
  • Protocol development
  • PMDA consultation
  • Feasibility

Experience by Therapeutic Area Past Five Years

STRONG LEADERSHIP IN JAPAN

Yasumasa Kurioka

As the PPD-SNBL general manager, Yasumasa Kurioka takes a unique approach to leverage the global power of PPD’s vast resources, expertise and capabilities.

Read More

Additional resources

The PPD-SNBL difference in Japan

The resources needed to execute global or local studies.

Download Brochure
Evidera and CSS collaborate in Japan

Develop joint real-world and patient-centered research capabilities.

Read Press Release
PPD-SNBL commended for staff growth and retention

Randstad Japan names PPD-SNBL a top-five growth business and desirable employer.

Read Press Release

Contact PPD-SNBL

We are ready to partner with you to help drive clinical trials and open opportunities in Japan.